The NLAAD webinar series will kick off TODAY at 3PM ET with a discussion about what is needed to make PrEP into the hands of everyone who needs it. Review the webinar listing below and register now to take part in these important conversations. Webinars are open to everyone. The sessions will include time for...
Category: HIV Resource
AIDSVu Releases New Data Highlighting Inequities in PrEP Use among Black and Hispanic People
AIDSVu has released PrEP use data and maps by race/ethnicity at the state-level for 2022, showing that while PrEP use has continued to increase on average by 56% each year since its approval in 2012, significant inequities remain in PrEP use among Black and Hispanic people and in the Southern region of the country. These...
Geographic mobility impacts vulnerability to HIV among gay and bisexual Latino migrants to the US
Gay and bisexual Latino migrants in the United States, especially but not only those who are undocumented, are vulnerable to higher rates of sexual risk behaviours and HIV transmission, a recent study published in Social Science and Medicine found. The study identified homophobia and HIV related stigma in their residential communities, barriers to well-paid work,...
NLAAD: HIV in Hispanics/Latinos During the year 2020
Credits: this summary of the impact of HIV among Hispanics/Latinos by gender, sexual orientation and age group has been prepared by Luis A. Mares, LMSW GENERAL Hispanic/Latino Americans in the United States have to deal with a variety of social determinants of health that put them in a precarious position when it comes to...
Registrations Open for NLAAD Webinar Series 2022
Tuesday October 4th, 3pm “A different PrEP Option: A Presentation for PrEP Professionals” Apretude is the first and only long acting injectable PrEP for reducing the risk of getting HIV. Join us to this presentation given by ViiV laboratories with information about this new important medical advance in the HIV field. [Registration link] Wednesday...
U.S. FDA Approves CABENUVA for Use Every Two Months, Expanding the Label of the First and Only Long-Acting HIV Treatment
TITUSVILLE, N.J., February 1, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the U.S. Food and Drug Administration (FDA) has approved an expanded label for CABENUVA (rilpivirine and cabotegravir) to be administered every two months for the treatment of HIV-1 in virologically suppressed adults (HIV-1 RNA less than 50 copies per...
AIDSVu Recognizes National Latinx AIDS Awareness Day
October 15 is National Latinx AIDS Awareness Day (NLAAD). This year’s theme, “Ending HIV is at your fingertips,” focuses on the tools already available to address the HIV epidemic, like HIV testing, PrEP, condom use, HIV treatment, and U=U, as we are dealing with the COVID-19 pandemic. Historically, HIV has disproportionately impacted Hispanic/Latinx Americans, and a broad...
NLAAD Presentation at Loisaida TV
Luis A Mares, LMSW , Director of Community Mobilization at the Latino Commission on AIDS was invited by the Loisaida Center TV from Acacia network, for one episode in their programing, to talk about NLAAD and the work the Commission does about not just on awareness about HIV in the Latinx Community, but about all...
Ryan White and Latinx AIDS Awareness Day
Latinos represent 26% of new HIV diagnoses in the United States, but make only 18.3% of the overall population (CDC, 2020). Most new HIV cases among Latinos are among men who have sex with men, MSM; these increases are concentrated in Arizona, California, Florida, Illinois, New York, Texas, and Puerto Rico (CDC, 2018). Nearly three-quarters of RWHAP clients are from racial/ethnic minority populations. According to the 2018 HRSA client...
Register for the Latest News: Advancing the Ending the HIV Epidemic Initiative during COVID-19
The Latino Commission on AIDS (LCOA) will host a webinar entitled “Advancing the Ending the HIV Epidemic Initiative during COVID-19” on Wednesday, October 14th. Guest speaker Harold Phillips, Chief Operating Officer of the Ending the HIV Epidemic: A Plan for America(EHE) initiative, will talk about EHE’s goals and how to achieve them while navigating the...